Delivery Order SPE2DB24D1104-SPE2DB24FYAF9

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $4,647.48 firm-fixed-price contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen holds several large Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999, to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,048.10 firm fixed-price contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has a period of performance through February 5, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,179.14 firm fixed-price contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM medical products. The contract has an ultimate completion date of March 5, 2025 and was awarded on March 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM. The $4,033.58 fixed-price contract has a completion date of September 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $2,819.78, is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through July 30, 2024. The award was made on July 29, 2024, and there is no set-aside designation indicated. Amerisourcebergen is a major supplier of...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. is a Delivery Order with a Firm Fixed Price valued at $1,761.96. The contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical supply item, with a completion date of January 10, 2025. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical that runs through November...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The contract has a firm fixed price of $1,722.10 and a completion date of May 15, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Amerisourcebergen holds...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a potential value of $3,581.40. The contract has a period of performance through February 26, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a potential value of $1,016.28 and a performance period through February 9, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,750.92 firm fixed-price delivery order is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYAF9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,081.16 firm fixed price contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The contract has an ultimate completion date of July 12, 2024.

Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 10/10/24, 9:19 AM